Amerise Biosciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported net loss was INR 0.392 million compared to INR 0.075 million a year ago. Basic loss per share from continuing operations was INR 0.01. Diluted loss per share from continuing operations was INR 0.01.
For the six months, net loss was INR 1.05 million compared to INR 0.472 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.01 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.01 a year ago.